“…For moderate intensity treatments, some data was available: younger age (Ayers et al, 2011), better perceived health (Schuurmans, 2009), lower neuroticism (Schuurmans et al, 2009), higher baseline symptoms (Wetherell et al, 2005b), presence of a comorbid diagnosis (Wetherell, Sorrell, Thorp & Patterson, 2005b), absence of subtle cognitive deficits or executive skill deficits (Caudle, 2007; Mohlman & Gorman, 2005), treatment credibility and homework adherence (Ayers et al, 2011, Gorenstein, et al, 2005, and Wetherell et al, 2005b). Likewise, for low intensity treatments, the following predictors of positive treatment outcome were identified: age ≥ than 60 years of age (Hui & Zhihui, 2016), shorter duration of illness (Hui & Zhihui, 2016), higher baseline levels of avoidance (Hui & Zhihui, 2016), treatment credibility (Hundt, 2013, Jones et al, 2016), homework adherence (Hundt et al, 2013), reduction in anxiety symptoms early in treatment (Bradford et al, 2011), and improvement in executive functioning during the course of treatment (Mohlman et al, 2008). …”